Tag: Featured

Vascular Video Series Part 6: Gaps in Vascular Care

This video is supported by an unrestricted educational grant.

Physician burnout: An Emerging National Epidemic

Results of two studies published in the latest issue of the JAMA…

Vascular Video Series Part 5: Gaps in Vascular Care

This video is supported by an unrestricted educational grant.

Early Discharge Following Uncomplicated TAVR Safe, According to a Meta-Analysis

A recent meta-analysis published in the Journal of American College of Cardiology…

Do Valsartan Contaminants NDMA and NDEA Bear A Potential Cancer Risk?

The discovery of Valsartan products that were contaminated with NDMA, in July…

Vascular Video Series Part 4: Vascular Risk

This video is supported by an unrestricted educational grant.

Can TTR levels Determine Long-term Prognosis in AFib Patients on Vitamin K Antagonists?

Findings from a Danish nationwide registry conducted among patients with Atrial Fibrillation…

Operator Experience of Atleast 225 Procedures Associated With Improved TAVR Outcomes

Findings from an international TAVR registry involving 16 centers and spanning over…

Vascular Video Series Part 3: The Polyvascular Disease Patient

This video is supported by an unrestricted educational grant.

Angiographic Completeness Not Associated With Outcomes Following FFR-guided PCI

Researchers have confirmed that the extent of residual angiographic disease calculated using…

Vascular Video Series Part 2: Underlying Risks of Vascular Disease

This video is supported by an unrestricted educational grant.

Vascular Video Series Part 1: Clinical Manifestations of Atherosclerosis

This video is supported by an unrestricted educational grant.

Coronary Microvascular Dysfunction: A Promising Therapeutic Target in Heart Failure with Preserved EF?

PROMIS-HFpEF (PRevalence Of MIcrovascular dySfunction in Heart Failure with Preserved Ejection Fraction)…

ESC at a Glance: The Trials Were Largely Negative, The Science Was Positive

The Canadian SCAD Study The Canadian SCAD study investigated the risk factors…

Lorcaserin proven safe as weight loss agent in obese patients

The selective serotonin 2c receptor agonist, Lorcaserin has been proven to be…